Watch our interview with Matthew Henn, Executive Vice President and Chief Scientific Officer of Seres Therapeutics.
Home » Matthew Henn (Seres Therapeutics): ‘Microbiome research will have a large impact on human health’
MicrobiomePost.com provides qualified scientific updates to healthcare professionals and to anyone who wants to know more about the microbiome.
Published by Clorofilla Srl.
© 2016-2023 Clorofilla Srl
Via Podgora 12/A, 20122, Milan, Italy – VAT: 05299040963
© ALL RIGHTS RESERVED